Pathological complete response to perioperative treatment with darolutamide plus ADT in locally advanced prostate cancer without PTEN or RB1 loss: a case report
Zhihui Zhang, Jiwei Zhai, Qimei Ma, Yuzhu Xiang, Jiajun Kan, Junhao Chu, Chunxiao Wei, Muwen Wang · 2026
Read Pathological complete response to perioperative treatment with darolutamide plus ADT in locally advanced prostate cancer without PTEN or RB1 loss: a case report by Zhihui Zhang, Jiwei Zhai, Qimei Ma, Yuzhu Xiang, Jiajun Kan, Junhao Chu, Chunxiao Wei, Muwen Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13272317.txt.
Description
Zhihui Zhang and coauthors report in 2026 a prostate cancer case where hormone treatment around surgery cleared all detectable cancer from the removed tissue. The 70-year-old patient had locally advanced disease invading the bladder wall and pelvic nodes, with a very high PSA level. His tumor kept two genes, PTEN and RB1, whose loss often predicts hormone resistance.
Treatment paired the androgen blocker darolutamide with a hormone-suppressing injection given every three months. Testosterone fell to castration level within a month, and PSA dropped sharply from its starting value near eighty-nine. The report explores gene status as a guide for choosing intensive hormone therapy before surgery.
Catalog record
| CREATOR | Zhihui Zhang, Jiwei Zhai, Qimei Ma, Yuzhu Xiang, Jiajun Kan, Junhao Chu, Chunxiao Wei, Muwen Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |